MBBS, BDS 2021: MPDME Releases Revised Schedule For College Level Admission Process Against The Stray Vacancies, Details
Madhya Pradesh : Through a recent notice, MPDME (Madhya Pradesh Directorate of Medical Education) has released a Revised Tentative Time Schedule for NEET UG Counseling with respect to the college level admission process against the stray vacancies in MBBS and BDS course for this academic year 2021-2022.
All the concerned candidates area advised to take note of the following schedule:
COLLEGE LEVEL ADMISSION AGAINST STRAY VACANCIES MBBS & BDS COURSE
S.no Events Duration No. of Days
1 Publication of vacancies and list of eligible candidates for filling of Stray vacancies. 6/4/2022 2 Day
2 lnvitation of online application (choice-filling) by eligible candidate on portal against vacancies. College wise merit list of applicants (real time merit) 10 times the number of college vacancies. 06-04-2022 To 07-04-2022 (t2:00 Midnight)
3 Reporting at college for Online Attendance. 08-04-2022 (Till 05:00 PM ) 1 Day
4 Admission (selected candidate as per attendence merit) 09-04-2022 (10:00 AM to 05:00 pM) 1 Day
To view the official Notice, click here : https://dme.mponline.gov.in/DMEUG/2021.pdf
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!